PAPER Wang SM, Kang DW, Um YH, Kim S, Lee CU, Scheltens P, Lim HK

Plasma oligomer beta-amyloid is associated with disease severity and cerebral amyloid deposition in Alzheimer's disease spectrum.

Alzheimers Res Ther. 2024 Mar 11;16(1):55. PubMed.

PAPER Keller JA, Sigurdsson S, Schmitz Abecassis B, Kant IM, Van Buchem MA, Launer LJ, van Osch MJ, Gudnason V, de Bresser J

Identification of Distinct Brain MRI Phenotypes and Their Association With Long-Term Dementia Risk in Community-Dwelling Older Adults.

Neurology. 2024 Apr 9;102(7):e209176. Epub 2024 Mar 12 PubMed.

PAPER Lu Y, Pike JR, Hoogeveen R, Walker K, Raffield L, Selvin E, Avery C, Engel S, Mielke MM, Garcia T, Heiss G, Palta P

Nonalcoholic Fatty Liver Disease and Longitudinal Change in Imaging and Plasma Biomarkers of Alzheimer Disease and Vascular Pathology.

Neurology. 2024 Apr 9;102(7):e209203. Epub 2024 Mar 12 PubMed.

PAPER Buhlin K, Eriksdotter M

[Oral diseases and dementia].

Lakartidningen. 2024 Mar 12;121 PubMed.

PAPER Nonaka T, Iwasaki Y, Horiuchi H, Satoh K

Detection limitations of prion seeding activities in blood samples from patients with sporadic prion disease.

BMC Neurol. 2024 Mar 11;24(1):92. PubMed.

PAPER Davidson JM, Zhang L, Yue GH, Di Ieva A

Fractal Dimension Studies of the Brain Shape in Aging and Neurodegenerative Diseases.

Adv Neurobiol. 2024;36:329-363. PubMed.

PAPER Díaz Beltrán L, Madan CR, Finke C, Krohn S, Di Ieva A, Esteban FJ

Fractal Dimension Analysis in Neurological Disorders: An Overview.

Adv Neurobiol. 2024;36:313-328. PubMed.

PAPER Wilson EL, Yu Y, Leal NS, Woodward JA, Patikas N, Morris JL, Field SF, Plumbly W, Paupe V, Chowdhury SR, Antrobus R, Lindop GE, Adia YM, Loh SH, Prudent J, Martins LM, Metzakopian E

Genome-wide CRISPR/Cas9 screen shows that loss of GET4 increases mitochondria-endoplasmic reticulum contact sites and is neuroprotective.

Cell Death Dis. 2024 Mar 11;15(3):203. PubMed.

PAPER Zhong J, Wang C, Zhang D, Yao X, Zhao Q, Huang X, Lin F, Xue C, Wang Y, He R, Li XY, Li Q, Wang M, Zhao S, Afridi SK, Zhou W, Wang Z, Xu Y, Xu Z

PCDHA9 as a candidate gene for amyotrophic lateral sclerosis.

Nat Commun. 2024 Mar 11;15(1):2189. PubMed.

PAPER Zhang Q, Xiong K

Editorial: Novel strategies to target cell death signaling in cancer and neurodegenerative diseases: new findings and mechanistic studies.

Front Cell Dev Biol. 2024;12:1383301. Epub 2024 Feb 26 PubMed.

PAPER Tsay HJ, Gan YL, Su YH, Sun YY, Yao HH, Chen HW, Hsu YT, Hsu JT, Wang HD, Shie FS

Reducing brain Aβ burden ameliorates high-fat diet-induced fatty liver disease in APP/PS1 mice.

Biomed Pharmacother. 2024 Apr;173:116404. Epub 2024 Mar 11 PubMed.

PAPER Han M, Saxton A, Currey H, Waldherr SM, Liachko NF, Kraemer BC

Transgenic Dendra2::tau expression allows in vivo monitoring of tau proteostasis in Caenorhabditis elegans.

Dis Model Mech. 2024 Mar 1;17(3) Epub 2024 Mar 28 PubMed.

PAPER Balakrishnan R, Jannat K, Choi DK

Development of dietary small molecules as multi-targeting treatment strategies for Alzheimer's disease.

Redox Biol. 2024 May;71:103105. Epub 2024 Mar 4 PubMed.

PAPER Almeida FC, Jesus T, Coelho A, Quintas-Neves M, Gauthreaux K, Teylan MA, Mock CN, Kukull WA, Crary JF, Oliveira TG

Psychosis in Alzheimer's disease is associated with specific changes in brain MRI volume, cognition and neuropathology.

Neurobiol Aging. 2024 Jun;138:10-18. Epub 2024 Mar 2 PubMed.

PAPER Therriault J, Ashton NJ, Pola I, Triana-Baltzer G, Brum WS, Di Molfetta G, Arslan B, Rahmouni N, Tissot C, Servaes S, Stevenson J, Macedo AC, Pascoal TA, Kolb HC, Jeromin A, Blennow K, Zetterberg H, Rosa-Neto P, Benedet AL

Comparison of two plasma p-tau217 assays to detect and monitor Alzheimer's pathology.

EBioMedicine. 2024 Apr;102:105046. Epub 2024 Mar 11 PubMed.